10/11, 6:24 AM (Source: TeleTrader)
more TeleTrader news

Vir Biotechnology IPO pricing values it at $2.2B

Vir Biotechnology's initial public offering pricing values the company at $2.2 billion, the company said in a press release as it announced that it priced its IPO at $20 per share. The company will offer over 7 million shares and hopes to raise $142.9 million.

The clinical-stage immunology company that uses technology to prevent and treat infectious diseases will start trading on Nasdaq on October 11. Its chosen symbol is VIR.

Softbank's Vision Fund and the Bill & Melinda Gates Foundation have stakes in Vir Biotechnology.

Breaking the News / VP